Matches in Nanopublications for { ?s ?p "[Lastly, the EMX2-high mRNA expressing group had statistically significant better recurrence-free survival (RFS) than the EMX2-low mRNA expression group in patients with adenocarcinoma (P < .001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- assertion description "[Lastly, the EMX2-high mRNA expressing group had statistically significant better recurrence-free survival (RFS) than the EMX2-low mRNA expression group in patients with adenocarcinoma (P < .001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP374548.RATknrw8ldUXAd0r7xgKqo4wfHlbuCsJfr3XiCY8DAcWk130_assertion description "[Lastly, the EMX2-high mRNA expressing group had statistically significant better recurrence-free survival (RFS) than the EMX2-low mRNA expression group in patients with adenocarcinoma (P < .001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP374548.RATknrw8ldUXAd0r7xgKqo4wfHlbuCsJfr3XiCY8DAcWk130_provenance.
- NP374515.RANNbRCLw9sRZrIlkrbeYWICMN7kTU-k9rFxhxLITvRbI130_assertion description "[Lastly, the EMX2-high mRNA expressing group had statistically significant better recurrence-free survival (RFS) than the EMX2-low mRNA expression group in patients with adenocarcinoma (P < .001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP374515.RANNbRCLw9sRZrIlkrbeYWICMN7kTU-k9rFxhxLITvRbI130_provenance.
- NP907031.RAEV2TCtPW_btA8BmXC0jWAyccN23jVOY6hh8g-y3wFPg130_assertion description "[Lastly, the EMX2-high mRNA expressing group had statistically significant better recurrence-free survival (RFS) than the EMX2-low mRNA expression group in patients with adenocarcinoma (P < .001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP907031.RAEV2TCtPW_btA8BmXC0jWAyccN23jVOY6hh8g-y3wFPg130_provenance.